Meyer Robert J. — SEC insider filings
SEC reporting owner CIK 1735298. 13 insider filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2020-08-19 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 4 filings — 25,150 shares, $58,365 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: purchase of 9,981 shares @ $2.06 ($20,561) in CHIMERIX INC, filed 2022-05-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CHIMERIX INC (CMRX) | Director | 9 | 5 legs · 25,150 sh · $58,365 | — | 13 |
| Translate Bio, Inc. (TBIO) | Director | 2 | — | — | 5 |
| Avalyn Pharma Inc. (AVLN) | Director | 2 | — | — | 1 |
Insider filings — Meyer Robert J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Avalyn Pharma Inc. (AVLN) | Grant/award (A): 31,182 (derivative) @ $0 | EDGAR |
| 2026-09-17 | 3 | Avalyn Pharma Inc. (AVLN) | Holdings only — no transactions reported | EDGAR |
| 2025-04-21 | 4 | CHIMERIX INC (CMRX) | Disposition to issuer (D): 35,150 @ $8.55 · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · +3 more | EDGAR |
| 2024-06-21 | 4 | CHIMERIX INC (CMRX) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | CHIMERIX INC (CMRX) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2023-05-10 | 4 | CHIMERIX INC (CMRX) | Purchase (P): 8,750 @ $1.14 | EDGAR |
| 2022-06-24 | 4 | CHIMERIX INC (CMRX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-05-20 | 4 | CHIMERIX INC (CMRX) | Purchase (P): 9,981 @ $2.06 · Purchase (P): 1,419 @ $2.05 | EDGAR |
| 2021-09-14 | 4 | Translate Bio, Inc. (TBIO) | Sale (S): 18,900 (derivative) @ $0 · Sale (S): 37,800 (derivative) @ $0 · Sale (S): 18,900 (derivative) @ $0 · Sale (S): 20,000 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | CHIMERIX INC (CMRX) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | Translate Bio, Inc. (TBIO) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-03-01 | 4 | CHIMERIX INC (CMRX) | Purchase (P): 1,500 @ $9.80 | EDGAR |
| 2020-08-19 | 4 | CHIMERIX INC (CMRX) | Purchase (P): 3,500 @ $2.92 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1735298 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs